Impact of 3′-exonuclease stereoselectivity on the kinetics of phosphorothioate oligonucleotide metabolism

被引:39
作者
Gilar, M [1 ]
Belenky, A [1 ]
Budman, Y [1 ]
Smisek, DL [1 ]
Cohen, AS [1 ]
机构
[1] Hybridon Inc, Cambridge, MA 02139 USA
来源
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 1998年 / 8卷 / 01期
关键词
D O I
10.1089/oli.1.1998.8.35
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
For the enzymatic digestion of a 25-mer phosphorothioate (PS) oligonucleotide, the reaction kinetics was previously determined to be the sum of two parallel processes: a fast and a very slow phase of digestion suggesting a two-exponential model. A characteristic metabolite profile was observed both in vitro and in vivo. This behavior is shown to be the result of the stereoselective cleavage of chiral R-configuration and S-configuration PS internucleotide linkages by 3'-exonucleases. The stereoselective nature of 3'-exonuclease action was analyzed by reverse-phase HPLC. The separation of eight diastereomers of the tetramer TTCT (5'-3') was used to follow the stereoselective course of exonuclease hydrolysis of PS internucleotide linkages. Degradation of the 25-mer parent compound having a 3' S-terminal internucleotide linkage was calculated to be more than 300 times slower than an analog with a 3'-terminal R-configuration. These results support an approach for protecting antisense oligonucleotides based on the chirality of only the 3'-end internucleotide linkage.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 31 条
  • [11] Kinetic analysis of the cleavage of natural and synthetic substrates by the Serratia nuclease
    Friedhoff, P
    Meiss, G
    Kolmes, B
    Piper, U
    Gimadutdinow, O
    Urbanke, C
    Pingoud, A
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 241 (02): : 572 - 580
  • [12] Kinetics of phosphorothioate oligonucleotide metabolism in biological fluids
    Gilar, M
    Belenky, A
    Smisek, DL
    Bourque, A
    Cohen, AS
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (18) : 3615 - 3620
  • [13] PHOSPHOROTHIOATE OLIGONUCLEOTIDE-DIRECTED TRIPLE-HELIX FORMATION
    HACIA, JG
    WOLD, BJ
    DERVAN, PB
    [J]. BIOCHEMISTRY, 1994, 33 (18) : 5367 - 5369
  • [14] JAROSZEWSKI JW, 1992, ANTI-CANCER DRUG DES, V7, P253
  • [15] Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: Diastereoselectivity of plasma 3'-exonuclease
    Koziolkiewicz, M
    Wojcik, M
    Kobylanska, A
    Karwowski, B
    Rebowska, B
    Guga, P
    Stec, WJ
    [J]. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (01): : 43 - 48
  • [16] Stereodifferentiation - The effect of P chirality of oligo(nucleoside phosphorothioates) on the activity of bacterial RNase H
    Koziolkiewicz, M
    Krakowiak, A
    Kwinkowski, M
    Boczkowska, M
    Stec, WJ
    [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (24) : 5000 - 5005
  • [17] Biochemical synthesis of chirally pure Rp oligonucleotide phosphorothioates
    Lackey, DB
    Patel, J
    [J]. BIOTECHNOLOGY LETTERS, 1997, 19 (05) : 475 - 478
  • [18] Quantitation of phosphorothioate oligonucleotides in human plasma
    Leeds, JM
    Graham, MJ
    Truong, L
    Cummins, LL
    [J]. ANALYTICAL BIOCHEMISTRY, 1996, 235 (01) : 36 - 43
  • [19] Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications
    McKay, RA
    Cummins, LL
    Graham, MJ
    Lesnik, EA
    Owens, SR
    Winniman, M
    Dean, NM
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (03) : 411 - 417
  • [20] SEPARATION AND CHARACTERIZATION OF DIASTEREOISOMERS OF ANTISENSE OLIGODEOXYRIBONUCLEOSIDE PHOSPHOROTHIOATES
    MURAKAMI, A
    TAMURA, Y
    WADA, H
    MAKINO, K
    [J]. ANALYTICAL BIOCHEMISTRY, 1994, 223 (02) : 285 - 290